Quote | John Wiley & Sons Inc. (NYSE:WLYB)
Last: | $40.94 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $40.94 |
High: | $0 |
Low: | $0 |
Volume: | 63 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | John Wiley & Sons Inc. (NYSE:WLYB)
2024-06-27 08:39:16 ET More on John Wiley & Sons, Inc. John Wiley & Sons: Still Less Compelling Than Treasuries John Wiley & Sons, Inc. (WLY) Q4 2024 Earnings Call Transcript John Wiley & Sons, Inc. 2024 Q4 - Results - Earnings Call Presentation ...
Company recently exceeded its Fiscal 2024 earnings guidance and sees strong core and GenAI momentum Wiley (NYSE: WLY and WLYB), a global leader in research and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.3525 per share on its Cl...
Message Board Posts | John Wiley & Sons Inc. (NYSE:WLYB)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest John Wiley Sons Cl B (JW.B) Headlines New Hypertension Guidelines Offer Practi | Stock_Tracker | investorshangout | 03/14/2014 8:34:21 PM |
chartguy89: JW.B Stock Charts Last: +0.11 $JW.B 1 Month Chart | chartguy89 | investorshangout | 03/05/2014 3:43:38 AM |
News, Short Squeeze, Breakout and More Instantly...
John Wiley & Sons Inc. Company Name:
WLYB Stock Symbol:
NYSE Market:
John Wiley & Sons Inc. Website:
Company recently exceeded its Fiscal 2024 earnings guidance and sees strong core and GenAI momentum Wiley (NYSE: WLY and WLYB), a global leader in research and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.3525 per share on its Cl...
A look at the top 10 most actives in the United States Sharps Technology Inc. (STSS) rose 39.8% to $0.4185 on volume of 56,031,365 shares Nuburu Inc. (BURU) fell 36.1% to $0.0933 on volume of 49,471,677 shares BioRestorative Therapies Inc (BRTX) rose 66.7% to $2.25 on volume of 46,968,012...
Exceeds FY24 earnings guidance and reports confident FY25 outlook and GenAI momentum Wiley (NYSE: WLY) today reported results for the fourth quarter and fiscal year ended April 30, 2024. HIGHLIGHTS FY24 Adjusted EBITDA and Adjusted EPS guidance exceeded; Adjusted Revenue i...